Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01187329 · ClinicalTrials.gov registry record · NA
The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01187329 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 100 participants.
The verdict
NCT01187329, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The overall research plan is to test the hypothesis that intraoperative treatment of hyperinsulinemic normoglycemic clamp (HNC) in cardiac surgical patients improves myocardial function and short-term outcomes compared with standard glucose management.
Interventions
- OTHER control group
- OTHER hyperinsulinemic normoglycemic clamp (HNC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01187329
The ClinicalTrials.gov registry entry for NCT01187329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which control group is the first listed.
NCT01187329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01187329 about?
NCT01187329 is a clinical study titled "The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose". The overall research plan is to test the hypothesis that intraoperative treatment of hyperinsulinemic normoglycemic clamp (HNC) in cardiac surgical patients improves myocardial function and short-term outcomes compared with standard glucose management.
What is the current status of trial NCT01187329?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01187329?
The interventions under investigation include: control group (OTHER), hyperinsulinemic normoglycemic clamp (HNC) (OTHER).
Who is sponsoring clinical trial NCT01187329?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.